08/12/2025
6:41 AM | Bicara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/31/2025
1:56 PM | Bicara Therapeutics (Subject)
Invus Global Management, LLC (Filed by)
| Form SCHEDULE 13G/A | |
07/17/2025
10:08 AM | Bicara Therapeutics (Subject)
FMR LLC (Filed by)
| Form SCHEDULE 13G/A | |
07/17/2025
10:11 AM | Bicara Therapeutics (Subject)
FMR LLC (Filed by)
| Form SCHEDULE 13G | |
06/18/2025
4:12 PM | Bicara Therapeutics (Issuer)
Meisner Lara (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
3:33 PM | Bicara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/10/2025
3:34 PM | Bicara Therapeutics (Issuer)
RA Capital Nexus Fund III, L.P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2025
3:37 PM | Bicara Therapeutics (Issuer)
Haviland Kate (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2025
3:26 PM | Bicara Therapeutics (Issuer)
Bowden Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2025
3:27 PM | Bicara Therapeutics (Issuer)
Simson Jake (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2025
3:28 PM | Bicara Therapeutics (Issuer)
Robertson Scott M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for BCAX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Bicara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
05/13/2025
6:43 AM | Bicara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2025
8:12 AM | Bicara Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/27/2025
6:45 AM | Bicara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2025
5:35 PM | Bicara Therapeutics (Issuer)
Meisner Lara (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2025
3:21 PM | Bicara Therapeutics (Subject)
Meisner Lara (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025
8:14 AM | Bicara Therapeutics (Subject)
FMR LLC (Filed by)
| Form SCHEDULE 13G | |
01/13/2025
7:02 AM | Bicara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/26/2024
3:30 PM | Bicara Therapeutics (Subject)
Invus Global Management, LLC (Filed by)
| Form SC 13G | |
09/26/2024
3:16 PM | Bicara Therapeutics (Subject)
Red Tree GP, LLC (Filed by)
| Form SC 13G | |
09/23/2024
3:17 PM | Bicara Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13D | |
09/18/2024
5:02 PM | Bicara Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund III, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
4:02 PM | Bicara Therapeutics (Issuer)
BONDERMAN DAVID (Reporting)
COULTER JAMES G (Reporting)
TPG GP A, LLC (Reporting)
WINKELRIED JON (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
4:10 PM | Bicara Therapeutics (Subject)
TPG GP A, LLC (Filed by)
| Form SC 13D | |
09/18/2024
10:54 AM | Bicara Therapeutics (Issuer)
FMR LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
10:54 AM | Bicara Therapeutics (Issuer)
FIL Ltd (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
10:57 AM | Bicara Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G | |
09/17/2024
5:16 PM | Bicara Therapeutics (Issuer)
DEERFIELD MANAGEMENT COMPANY, L.P. (0001009258) (Reporting)
Deerfield Mgmt L.P. (Reporting)
Deerfield Mgmt V, L.P. (Reporting)
DEERFIELD PARTNERS, L.P. (Reporting)
Deerfield Private Design Fund V, L.P. (Reporting)
Flynn James E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
4:49 PM | Bicara Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund III, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
3:35 PM | Bicara Therapeutics (Issuer)
Mazumdar-Shaw Kiran (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
3:35 PM | Bicara Therapeutics (Issuer)
Robertson Scott M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
3:38 PM | Bicara Therapeutics (Issuer)
Haviland Kate (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
3:39 PM | Bicara Therapeutics (Issuer)
Biocon Ltd (Reporting)
Biocon Pharma Inc. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
3:41 PM | Bicara Therapeutics (Issuer)
Simson Jake (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
3:42 PM | Bicara Therapeutics (Issuer)
LONBERG NILS (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
3:45 PM | Bicara Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
